Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
04/1999
04/07/1999CN1212884A Method for preparing piles medicament
04/06/1999US5892099 Autoimmune disease, bone disorders, liver damage, cardiovascular disorders
04/06/1999US5892045 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
04/06/1999US5892039 Piperazino derivatives as neurokinin antagonists
04/06/1999US5891909 Amidinohydrazones as protease inhibitors
04/06/1999US5891899 Pharmaceutical xanthene compounds
04/06/1999US5891890 Benzamide derivatives, anti-ulcer drug, and antibacterial drug
04/06/1999US5891878 Enzyme inhibitors of phosphodiesterase or tumor necrosis factor
04/06/1999US5891868 Methods for treating postmenopausal women using ultra-low doses of estrogen
04/06/1999US5891672 Polynucleotides encoding GTP cyclohydrolase II (ribA)
04/06/1999US5891670 Tetracycline resistance protein
04/01/1999WO1999015671A1 Hepatitis b virus polypeptides
04/01/1999WO1999015525A1 Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
04/01/1999WO1999015501A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents
04/01/1999WO1999015494A1 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
04/01/1999WO1999015493A1 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors
04/01/1999WO1999015210A2 Bioadhesive compositions and methods for topical administration of active agents
04/01/1999WO1999015194A1 Combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
04/01/1999WO1999015171A1 Nicotine compositions and methods of formulation thereof
04/01/1999WO1999015164A1 Amide derivatives for the treatment of diseases mediated by cytokines
04/01/1999WO1999015160A2 Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies
04/01/1999WO1999003826A3 Metalloproteinase inhibitors
04/01/1999WO1999002552A3 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof
04/01/1999DE19742263A1 Neue spezifische Immunophilin-Liganden als Antiasthmatika, Antiallergika, Antirheumatika, Immunsuppressiva, Antipsoriatika, Neuroprotektiva New specific immunophilin ligands as anti-asthmatics, anti-allergic, anti-inflammatory drugs, immunosuppressants, anti-psoriasis, neuroprotective agents
04/01/1999CA2304879A1 New tetracycles, process for their production and pharmaceutical preparations containing these compounds
04/01/1999CA2304451A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents
04/01/1999CA2304397A1 Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
04/01/1999CA2304042A1 Nicotine compositions and methods of formulation thereof
04/01/1999CA2303943A1 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
04/01/1999CA2303918A1 Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies
04/01/1999CA2300051A1 Amide derivatives for the treatment of diseases mediated by cytokines
04/01/1999CA2246004A1 A kringle-related clone, hthbz47
03/1999
03/31/1999EP0905250A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratA
03/31/1999EP0905248A1 Staphylococcus aureus MurE protein and nucleic acids encoding it
03/31/1999EP0905245A1 Staphylococcal polypeptides Spo0J1
03/31/1999EP0905243A2 Polynucleotides from Staphylococcus aureus expressed in infected tissue
03/31/1999EP0905237A2 PIGR-2 A member of immunoglobulin gene superfamily
03/31/1999EP0905139A2 5 ring heterocyles, process for preparation, use as inhibitors of leukocyte adhesion and pharmaceutical preparations comprising them
03/31/1999EP0905136A1 Tetrahydro gamma-carbolines
03/31/1999EP0905126A1 Metalloproteinase inhibitors
03/31/1999EP0904260A1 Inhibition of matrix metalloproteases by 2-(omega-aroylalkyl)-4-biaryl-oxobutyric acids
03/31/1999EP0904110A1 Nitric oxide donors capable of reducing toxicity from drugs
03/31/1999EP0904099A1 A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent
03/31/1999EP0904092A1 Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use
03/31/1999EP0762886A4 Icam-1/lfa-1 short-chain peptides and method of using same
03/31/1999EP0660711B1 Novel use of inhibitors of phosphodiestersase iv
03/31/1999EP0591275B1 Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions
03/31/1999CN1212689A Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
03/31/1999CN1212622A Use of antagnoist of PPAR-alpha and PPAR-gamma for treatment of syndrom X
03/31/1999CN1212620A Mercapto derivatives as inhibitors of cyclooxygenases
03/31/1999CN1212155A Drug for curing hepatitis B
03/31/1999CN1212151A Health-care products composition
03/31/1999CN1042730C Method for preparing pyrazolopyridine compound
03/30/1999US5889178 N-(2,2-diphenylethyl)-derivatives
03/30/1999US5889049 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
03/30/1999US5889038 Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds
03/30/1999US5889022 Psychological disorders
03/30/1999US5889021 Active Compounds
03/30/1999US5889002 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
03/30/1999US5888978 Method for reducing the severity of gastro-intestinal damage
03/30/1999US5888969 Crohn*s disease
03/30/1999US5888771 Gene products as targets for the development of antibiotics.
03/30/1999US5888770 Spoiiie
03/30/1999US5888535 Antiulcer agents, reduced side effects
03/30/1999US5888529 After surgery
03/30/1999CA2085975C Dentinal desensitizing compositions
03/25/1999WO1999014346A2 SENSE mRNA THERAPY
03/25/1999WO1999014340A1 Human prl-1 phosphatase
03/25/1999WO1999014328A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999WO1999014231A2 Bifidus stimulating peptides and its uses
03/25/1999WO1999014213A1 Substituted chroman derivatives
03/25/1999WO1999014212A1 Substituted chroman derivatives
03/25/1999WO1999014207A1 Substituted indan derivatives
03/25/1999WO1999013894A2 Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c
03/25/1999WO1999013872A1 Antimicrobials
03/25/1999WO1998056398A3 A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
03/25/1999WO1998051665A3 Novel macrocyclic compounds as metalloprotease inhibitors
03/25/1999WO1998050032A9 BETA-LACTAM INHIBITORS OF CoA-IT
03/25/1999DE19742014A1 Use of new and known tetracyclene compounds as phospholipase inhibitors
03/25/1999CA2382376A1 Novel polypeptides and nucleic acids encoding pro287 which are useful for treating disorders of the pancreas
03/25/1999CA2304982A1 Sense mrna therapy
03/25/1999CA2304037A1 Substituted chroman derivatives
03/25/1999CA2303926A1 Substituted chroman derivatives
03/25/1999CA2303839A1 Substituted indan derivatives
03/25/1999CA2303834A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/25/1999CA2303227A1 Human prl-1 phosphatase
03/25/1999CA2302834A1 Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c
03/25/1999CA2302251A1 Antimicrobial agent
03/25/1999CA2244971A1 Mure
03/24/1999EP0903353A1 Imidazolidine derivates, their preparation and use, and pharmaceutical compositions containing them
03/24/1999EP0903349A2 CCR-3 receptor antagonists
03/24/1999EP0903345A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid
03/24/1999EP0903148A2 Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
03/24/1999EP0784619B1 Phenyl-oxo-alkyl-(4-piperidinyl)benzoate derivatives
03/24/1999EP0773777B1 A drinking system and mouthpiece for use therein
03/24/1999EP0716650B1 Indole and indoline derivatives as 5ht1d receptor antagonists
03/24/1999CN1211983A Azabicyclic esters of carbamic acids useful in therapy
03/24/1999CN1211923A Ligands to enhance cellular uptake of biomolecules
03/24/1999CN1211572A Cyclic amine derivatives-CCR-3 receptor antagonists
03/24/1999CN1211569A Substituted quinolone derivatives and pharmaceuticals containing the same
1 ... 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 ... 1258